(1)
Шеремета, Л. М. ABOUT ADVERSE REACTIONS AND VALUE CRITERIA "BENEFIT RISK" WHEN USING DRUGS THAT AFFECT THE NERVOUS SYSTEM (according to Reports, Registered in Ivano-Frankivsk Region During 2007-2012). pulse 2019, 100-105.